Results 71 to 80 of about 100,300 (318)

Drug Eluting Stents en Belgique

, 2007
A côté des« stents » métalliques classiques, il y a, depuis quelques années, aussi des stents spéciaux avec médicament incorporé, pour traiter le rétrécissement des artères coronaires : les « drug eluting stents ». Le médicament est supposé empêcher une nouvelle constriction de l’artère. Quelle est l’efficacité de cette nouvelle technique ? A-t-elle un
Neyt, Mattias, Van Brabandt, Hans, Devriese, Stephan, Mahieu, Joris, De Ridder, Annemieke, De Graeve, Diana, De Laet, Chris   +6 more
openaire   +1 more source

Radial capacity and hemodynamics evaluation in vitro and implantable feasibility validation in vivo of thinner bioresorbable polymer vascular stents

BMEMat, EarlyView.
A series of in vitro experiments, numerical simulations and in vivo experiments were conducted to jointly evaluate the effects of different thicknesses of bioabsorbable polymer vascular stents on their radial capacity, hemodynamics and in vivo outcomes.
Chong Chen, Tao Li, Zhongyou Li, Jingyuan Zhou, Zhuo Zhang, Yan Xiong, Rifang Luo, Yu Chen, Yunbing Wang, Ping Fu   +9 more
wiley   +1 more source

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform

Clinical Medicine Insights: Cardiology, 2013
Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing.
Matthew G. Whitbeck, Robert J. Applegate
doaj   +1 more source

Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort

Indian Heart Journal, 2014
Aims: The use of biodegradable-polymer drug-eluting stents has been shown to provide favorable results when compared with durable polymer drug-eluting stents and long-term follow up data have recently shown significant reductions in terms of very late ...
E. Xhepa, T. Tada, S. Cassese, L. King, I. Ott, M. Fusaro, A. Kastrati, R.A. Byrne   +7 more
doaj   +1 more source

Drug eluting stents in 2005 [PDF]

Heart, 2005
In the last 3–5 years there has been a major shift in the management of symptomatic, obstructive coronary artery disease, with a move from predominantly surgical to increasingly a percutaneous approach. The perceived benefits of percutaneous coronary intervention (PCI) include patient convenience, ease of service expansion, and the fact that more ...
openaire   +2 more sources

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The treatment of coronary bifurcation lesions (CBL) remains complex and associated with a higher rate of long‐term adverse cardiovascular events due to anatomical and procedural complexity. Aims We compared procedural outcomes between a drug coated balloon (DCB) only approach and a 2nd generation drug eluting stent (DES) for ...
Natasha Corballis, Ioannis Merinopoulos, U. Bhalraam, Tharusha Gunawardena, Vasiliki Tsampasian, Rajkumar Natarajan, Upul Wickramarachchi, Mohamed Mohamed, Allan Clark, Mamas A. Mamas, Vassilios S. Vassiliou, Simon Eccleshall, SPARTAN‐Norfolk Consortium, Tim Gilbert, Clint Maart, Johannes Reinhold, Paul Richardson, Alisdair Ryding, Trevor Wistow, Chris Sawh, Sulfi Sreekumar   +20 more
wiley   +1 more source

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

Drug-eluting balloon in the treatment of a recurrent in-stent restenosis of drug-eluting stent [PDF]

Orvosi Hetilap, 2010
A koszorúér-betegség alapját jelentő atheroscleroticus folyamatok gyógyszeres kezelése mellett a percutan intervenciós módszer szerepe az utóbbi évtizedekben egyre jelentősebb. A stentek elterjedésével a percutan koszorúér-intervenció akut sikerrátája jelentős javulást mutatott, azonban a hagyományos fémstentekben keletkezett instentrestenosis újabb ...
Béla, Merkely, Zoltán, Jambrik
openaire   +2 more sources

OCT‐Guided Distal Left Main Bifurcation PCI: Mid‐Term Outcomes From a Multicenter South‐Asian Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Optical coherence tomography (OCT)‐guided percutaneous coronary intervention (PCI) enhances treatment of complex coronary artery lesions, including left main (LM) disease, by enabling lesion morphology assessment and stent optimization, thereby reducing major adverse cardiac events (MACE).
Prathap Kumar, Shaneez Najmy, Manu Rajendran, Ali Shafeeq, Blessvin Jino   +4 more
wiley   +1 more source

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Cardiology Research and Practice, 2020
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery.
Dai-Min Zhang, Shaoliang Chen
doaj   +1 more source